NDC properties for "terbutaline sulfate 1 MG per 1 ML Injection" (RxCUI 857635)
About this data
The tables show NDC propoerties for terbutaline sulfate 1 MG per 1 ML Injection with the RxCUI 857635
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for terbutaline sulfate 1 MG per 1 ML Injection (RxCUI 857635)
| ANDA | ANDA076887 |
|---|---|
| ANDA | ANDA078630 |
| ANDA | ANDA200122 |
| MMSL_CODE | BD3286 |
| MMSL_CODE | CD3286 |
| RxCUI | 857635 |
| SNOMEDCT | 374631006 |
| SPL_SET_ID | 0f4d3249-e022-40b6-b93d-f605e8522207 |
| SPL_SET_ID | 2a4be57a-a3df-4aa5-be52-845b75e78b3b |
| SPL_SET_ID | 613df3cb-4d55-4d12-ab08-a932481aaa0b |
| SPL_SET_ID | 69488fbd-0193-570f-e053-2991aa0af0ed |
| SPL_SET_ID | 6a22b62c-4ee1-49df-e053-2a91aa0a3e52 |
| SPL_SET_ID | 81e7751e-4e44-d529-e053-2a91aa0a7646 |
| SPL_SET_ID | 9f4b177e-4d7d-4255-afeb-522c7d4594c6 |
| SPL_SET_ID | cec31032-f366-4524-9e01-63146e473b2b |
| VUID | 4004617 |
| Prescribable Synonym | terbutaline sulfate 1 MG in 1 ML Injection |
| RXNAV_STR | 1 ML terbutaline sulfate 1 MG/ML Injection |
| RxNorm Name | 1 ML terbutaline sulfate 1 MG/ML Injection |
| RxNorm Synonym | terbutaline sulfate 1 MG per 1 ML Injection |
| Related queries | Interactions (for RxCUI 857635) |
NDC Properties
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |
NDC Item 00143937501
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-01 |
| NDC Item | 00143937501 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143937510
| NDC 9 | 0143-9375 |
|---|---|
| NDC 10 | 0143-9375-10 |
| NDC Item | 00143937510 |
| Packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 651710 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9375 |
NDC Item 00143974601
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-01 |
| NDC Item | 00143974601 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00143974610
| NDC 9 | 0143-9746 |
|---|---|
| NDC 10 | 0143-9746-10 |
| NDC Item | 00143974610 |
| Packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| ANDA | ANDA078630 |
| FDA SPL set id | 760353 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9746 |
NDC Item 00404996201
| NDC 9 | 0404-9962 |
|---|---|
| NDC 10 | 0404-9962-01 |
| NDC Item | 00404996201 |
| Packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
| ANDA | ANDA076887 |
| FDA SPL set id | 711310 |
| Labeler | Henry Schein, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0404-9962 |
NDC Item 55390010110
| NDC 9 | 55390-101 |
|---|---|
| NDC 10 | 55390-101-10 |
| NDC Item | 55390010110 |
| Packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA076770 |
| FDA SPL set id | 17160 |
| Labeler | Bedford Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2011-12-31 |
| Marketing effective time low | 2004-04-28 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 55390-101 |
NDC Item 63323066500
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-00 |
| NDC Item | 63323066500 |
| Packaging | 1 mL in 1 VIAL, SINGLE-USE |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 63323066501
| NDC 9 | 63323-665 |
|---|---|
| NDC 10 | 63323-665-01 |
| NDC Item | 63323066501 |
| Packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
| ANDA | ANDA076887 |
| FDA SPL set id | 650769 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-03-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-665 |
NDC Item 70860080101
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-01 |
| NDC Item | 70860080101 |
| Packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 70860080141
| NDC 9 | 70860-801 |
|---|---|
| NDC 10 | 70860-801-41 |
| NDC Item | 70860080141 |
| Packaging | 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 353618 |
| Labeler | Athenex Pharmaceutical Division, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-08-31 |
| Marketing effective time low | 2017-02-22 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70860-801 |
NDC Item 71872708001
| NDC 9 | 71872-7080 |
|---|---|
| NDC 10 | 71872-7080-1 |
| NDC Item | 71872708001 |
| Packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
| ANDA | ANDA078630 |
| FDA SPL set id | 711465 |
| Labeler | Medical Purchasing Solutions. LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-05-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7080 |
NDC Item 71872713001
| NDC 9 | 71872-7130 |
|---|---|
| NDC 10 | 71872-7130-1 |
| NDC Item | 71872713001 |
| Packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 448756 |
| Labeler | Medical Purchasing Solutions, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-02-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71872-7130 |
NDC Item 72843010110
| NDC 9 | 72843-101 |
|---|---|
| NDC 10 | 72843-101-10 |
| NDC Item | 72843010110 |
| Packaging | 10 VIAL in 1 BOX (72843-101-10) / 1 mL in 1 VIAL |
| ANDA | ANDA200122 |
| FDA SPL set id | 372809 |
| Labeler | UBI Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72843-101 |